ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock VRAYQ vs. SDCCQ, GMVDF, AHPI, NMRD, MOTS, UTRS, VIVE, DRTSW, ANZUW, and IONMShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Motus GI (MOTS), Minerva Surgical (UTRS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), and Assure (IONM). These companies are all part of the "medical equipment" industry. ViewRay vs. SmileDirectClub G Medical Innovations Allied Healthcare Products Nemaura Medical Motus GI Minerva Surgical Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Assure SmileDirectClub (NASDAQ:SDCCQ) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, community ranking, analyst recommendations, risk, dividends, media sentiment and valuation. Do institutionals & insiders believe in SDCCQ or VRAYQ? 0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 15.5% of ViewRay shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 2.5% of ViewRay shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is SDCCQ or VRAYQ more profitable? Company Net Margins Return on Equity Return on Assets SmileDirectClubN/A N/A N/A ViewRay N/A N/A N/A Does the media favor SDCCQ or VRAYQ? In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score. Company Overall Sentiment SmileDirectClub Neutral ViewRay Neutral Which has more risk and volatility, SDCCQ or VRAYQ? SmileDirectClub has a beta of 1.87, indicating that its share price is 87% more volatile than the S&P 500. Comparatively, ViewRay has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500. Does the MarketBeat Community favor SDCCQ or VRAYQ? SmileDirectClub and ViewRay both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformSmileDirectClubN/AN/AViewRayN/AN/A Which has preferable earnings & valuation, SDCCQ or VRAYQ? SmileDirectClub has higher revenue and earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmileDirectClub$470.74M0.00-$86.40MN/AN/AViewRay$102.21M0.00-$107.33MN/AN/A SummarySmileDirectClub beats ViewRay on 4 of the 5 factors compared between the two stocks. Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18,000.00$3.26B$5.38B$8.39BDividend YieldN/A1.72%5.21%4.10%P/E RatioN/A16.6026.7619.71Price / SalesN/A85.43389.71117.54Price / CashN/A44.0938.2534.62Price / BookN/A3.736.784.50Net Income-$107.33M$94.03M$3.23B$248.18M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18,000.00$102.21M0.00300Gap DownSDCCQSmileDirectClubN/A$0.00-80.0%N/A-92.3%$40,000.00$470.74M0.002,700Gap DownGMVDFG Medical InnovationsN/A$0.00-50.0%N/A-99.0%$26,000.00$4.42M0.0072AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150Gap UpNMRDNemaura MedicalN/AN/AN/AN/A$4,000.00$3,017.000.0040MOTSMotus GIN/A$0.00flatN/A-99.7%$2,000.00$319,000.000.0030UTRSMinerva SurgicalN/A$0.00+∞N/AN/A$1,000.00$51.69M0.00160VIVEViveve MedicalN/A$0.00flatN/A-66.7%$1,000.00$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.25+3.3%N/A+13.1%$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.07+19.8%N/AN/A$0.00N/A0.002IONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130 Related Companies and Tools Related Companies SmileDirectClub Alternatives G Medical Innovations Alternatives Allied Healthcare Products Alternatives Nemaura Medical Alternatives Motus GI Alternatives Minerva Surgical Alternatives Viveve Medical Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Assure Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRAYQ) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
